Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.19 USD | +6.83% | -12.75% | +151.72% |
20/06 | Kiromic BioPharma, Inc. Provides Updates on Its Deltacel-01 Clinical Trial | CI |
07/06 | Kiromic Biopharma, Inc. Issues 25% Senior Secured Convertible Promissory Note | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationQuarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+151.72% | 3.38M | |
+15.20% | 121B | |
+19.67% | 113B | |
+18.95% | 26.02B | |
-23.86% | 19.39B | |
-19.03% | 15.91B | |
-20.90% | 15.09B | |
-46.14% | 15.06B | |
+63.85% | 14.93B | |
+4.49% | 13.85B |
- Stock Market
- Equities
- KRBP Stock
- News Kiromic BioPharma, Inc.
- Kiromic BioPharma Signs Sponsored Research Agreement to Expand Gamma Delta T Cell Product Pipeline